MMJ International Urges DEA to Accelerate Federal Cannabis Medicine Access for Huntington’s Patients

WASHINGTON, D.C. — MMJ International Holdings, a U.S.-based pharmaceutical developer of federally compliant cannabis-derived therapies, has issued a Thanksgiving message...